Investigating The Efficacy of Ruxolitinib and CHIR-99021 in Targeting Pediatric Neuroblastoma Stem Cells
Neuroblastoma is the most common malignant tumor of infancy and accounts for 10% of all childhood cancers. The high biological and clinical heterogeneity of this tumor leads to differences in clinical outcomes ranging from benign tumors that regress spontaneously to metastatic tumors that are ultima...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | masterThesis |
| منشور في: |
2021
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/13649 https://doi.org/10.26756/th.2022.262 http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|